Evidence map›Paper›PMID 33953344›Full record

ArticleEuropean journal of human genetics : EJHG2021

International transfers of personal data for health research following Schrems II: a problem in need of a solution.

Dara Hallinan, Alexander Bernier, Anne Cambon-Thomsen, Francis P Crawley, Diana Dimitrova, Claudia Bauzer Medeiros, Gustav Nilsonne, Simon Parker, Brian Pickering, Stéphanie Rennes

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Fond farewell to clinical utility gene cards.European journal of human genetics : EJHG · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dara HallinanFIZ Karlsruhe-Leibniz-Institut für Informationsinfrastruktur, Hermann-von-Helmholtz-Platz 1, Eggenstein-Leopoldshafen, Germany. dara.hallinan@fiz-karlsruhe.de.ORCID http://orcid.org/0000-0002-1160-821X
Alexander BernierMcGill University Faculty of Medicine, Centre of Genomics and Policy, Montreal, Canada.
Anne Cambon-ThomsenCNRS, Center for Epidemiology and Research in POPulation health (CERPOP), Université de Toulouse, Inserm, UPS, Joint Unit 1295, Toulouse, France.ORCID http://orcid.org/0000-0001-8793-3644
Francis P CrawleyGood Clinical Practice Alliance-Europe (GCPA) and Strategic Initiative for Developing Capacity in Ethical Review (SIDCER), Leuven, Belgium.ORCID http://orcid.org/0000-0002-6893-5916
Diana DimitrovaFIZ Karlsruhe-Leibniz-Institut für Informationsinfrastruktur, Hermann-von-Helmholtz-Platz 1, Eggenstein-Leopoldshafen, Germany.
Claudia Bauzer MedeirosInstitute of Computing, University of Campinas, Campinas, Brazil.ORCID http://orcid.org/0000-0003-1908-4753
Gustav NilsonneDepartment of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
Simon ParkerCancer Research UK, London, UK.
Brian PickeringUniversity of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0002-6815-2938
Stéphanie RennesINRAE, Direction des affaires juridiques, Paris, France.ORCID http://orcid.org/0000-0003-1458-7773

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On 16 July 2020, the Court of Justice of the European Union issued their decision in the Schrems II case concerning Facebook's transfers of personal data from the EU to the US. The decision may have significant effects on the legitimate transfer of personal data for health research purposes from the EU. This article aims: (i) to outline the consequences of the Schrems II decision for the sharing of personal data for health research between the EU and third countries, particularly in the context of the COVID-19 pandemic; and, (ii) to consider certain options available to address the consequences of the decision and to facilitate international data exchange for health research moving forward.

Indexed as

PandemicsCOVID-19European UnionHumansInformation DisseminationPrivacyResearchSARS-CoV-2Social MediaUnited States

Identifiers

PMID33953344
PMCPMC8099706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.